EGFR and cancer: For example, metabolites such as butyrate and ursodeoxycholic acid have been shown to finely tune EGFR, VEGF, and PI3K/AKT/mTOR signaling—cascades central to both cancer biology and muscle metabolism—thereby modulating cellular energy flux, inflammatory responses, and tissue-repair processes (Gong et al., 2024).